Advanced search
Publication Cover
Leukemia & Lymphoma Volume 25, 1997 - Issue 5-6
Submit an article Journal homepage
28
Views
39
CrossRef citations to date
0
Altmetric
Original Article

The Use of a Sequential High Dose Recombinant Interleukin 2 Regimen After Autologous Bone Marrow Transplantation Does Not Improve the Disease Free Survival of Patients with Acute Leukemia Transplanted in First Complete Remission

Didier Blaise The Transplant Units oflnstitut Paoli Calmettes, Marseille; The Transplant Units oflnstitut Paoli Calmettes, Marseille
,
Michel Attal CHU Purpan, Toulouse
,
Jose Luis Pico Institut Gustave Roussy, Villejuif
,
Josy Reiffers 0CHU Haut Lévèque, Pessac
,
Anne-Marie Stoppa The Transplant Units oflnstitut Paoli Calmettes, Marseille
,
Coralie Bellanger CHU Necker, Paris
,
Lysiane Molina Hôpital Albert Michallon, Grenoble
,
Gerard Nedellec Hopital Val de Grace, Paris
,
Jean Paul Vernant CHU Henri Mondor, Créteil
,
Michel Legros CAC Jean-Perrin, Clermont Ferrand
,
Raul Gabus The Transplant Units oflnstitut Paoli Calmettes, Marseille
,
Françoise Huguet CHU Purpan, Toulouse
,
Maud Brandely Association pour la Recherche sur le Cancer, ARC, Villejuif, France
,
Thierry Hercend Rounel Liclaf, Normainville, France
,
Daniel Olive The Transplant Units oflnstitut Paoli Calmettes, Marseille
&
Dominique Maraninchi The Transplant Units oflnstitut Paoli Calmettes, Marseille
 show all
Pages 469-478 | Published online: 01 Jul 2009

Citations (39)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Fredrik B Thorén, Ana I Romero, Mats Brune & Kristoffer Hellstrand. (2009) Histamine dihydrochloride and low-dose interleukin-2 as post-consolidation immunotherapy in acute myeloid leukemia. Expert Opinion on Biological Therapy 9:9, pages 1217-1223.
Read now
Sergio Rutella, Luca Pierelli, Simona Sica, Carlo Rumi & Giuseppe Leone. (2001) Transplantation of Autologous Peripheral Blood Progenitor Cells: Impact of CD34-Cell Selection on Immunological Reconstitution. Leukemia & Lymphoma 42:6, pages 1207-1220.
Read now
Dominique Maraninchi, Norbert Vey, Patrice Viens, Anne-Marie Stoppa, Eric Archimbaud, Michel Attal, Daniel Baume, Reda Bouabdallah, Francois Demeoq, Joel Fleury, Mauricette Michallet, Daniel Olive, Josy Reiffers, Daniele Sainty, Antonio Tabilio, Pierre Tiberghien, Maud Brandely, Thierry Hercend & Didier Blaise. (1998) A Phase II Study of Interleukin-2 in 49 Patients with Relapsed or Refractory Acute Leukemia. Leukemia & Lymphoma 31:3-4, pages 343-349.
Read now

Articles from other publishers (36)

Chenyu Lin, Mitchell E. Horwitz & Lindsay A. M. Rein. (2022) Leveraging Natural Killer Cell Innate Immunity against Hematologic Malignancies: From Stem Cell Transplant to Adoptive Transfer and Beyond. International Journal of Molecular Sciences 24:1, pages 204.
Crossref
Peter Valent, Irina Sadovnik, Gregor Eisenwort, Karin Bauer, Harald Herrmann, Karoline V. Gleixner, Axel Schulenburg, Werner Rabitsch, Wolfgang R. Sperr & Dominik Wolf. (2019) Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML. International Journal of Molecular Sciences 20:17, pages 4233.
Crossref
Rohtesh S. Mehta, Brion Randolph, May Daher & Katayoun Rezvani. (2018) NK cell therapy for hematologic malignancies. International Journal of Hematology 107:3, pages 262-270.
Crossref
Rohtesh S. Mehta & Katayoun Rezvani. (2018) Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer. Frontiers in Immunology 9.
Crossref
Peter H. Wiernik. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 375 407 .
Rohtesh S. Mehta & Katayoun Rezvani. (2016) Can we make a better match or mismatch with KIR genotyping?. Hematology 2016:1, pages 106-118.
Crossref
Angélica Cuapio, Mirte Post, Sabine Cerny-Reiterer, Karoline V. Gleixner, Gabriele Stefanzl, Jose Basilio, Susanne Herndlhofer, Wolfgang R. Sperr, Nicolaas H.C. Brons, Emilio Casanova, Jacques Zimmer, Peter Valent & Erhard Hofer. (2016) Maintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56bright NK cell subpopulations in patients with acute myeloid leukemia and supports their activation. Oncotarget 7:29, pages 46466-46481.
Crossref
Jochen Vasold, Michaela Wagner, Heidrun Drolle, Christian Deniffel, Alexander Kütt, Robert Oostendorp, Silvia Sironi, Christina Rieger & Michael Fiegl. (2015) The bone marrow microenvironment is a critical player in the NK cell response against acute myeloid leukaemia in vitro. Leukemia Research 39:2, pages 257-262.
Crossref
Peter H. Wiernik. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 375 401 .
Marc BuysePierre SquiffletBeverly J. LangeTodd A. AlonzoRichard A. LarsonJonathan E. KolitzStephen L. GeorgeClara D. BloomfieldSylvie CastaigneSylvie ChevretDidier Blaise, Dominique Maraninchi, Kathryn J. Lucchesi & Tomasz Burzykowski. (2011) Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia. Blood 117:26, pages 7007-7013.
Crossref
A. I. Romero, F. B. Thorén, J. Aurelius, G. Askarieh, M. Brune & K. Hellstrand. (2009) Post-consolidation Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in AML. Scandinavian Journal of Immunology 70:3, pages 194-205.
Crossref
Gheath Alatrash & Jeffrey J. Molldrem. 2010. Acute Myelogenous Leukemia. Acute Myelogenous Leukemia 237 255 .
Richard M. Stone, Daniel J. DeAngelo, Anna Janosova, Ilene Galinsky, Christine Canning, Jerome Ritz & Robert J. Soiffer. (2008) Low dose interleukin‐2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission. American Journal of Hematology 83:10, pages 771-777.
Crossref
Edwin P. Alyea. (2008) Modulating graft-versus-host disease to enhance the graft-versus-leukemia effect. Best Practice & Research Clinical Haematology 21:2, pages 239-250.
Crossref
A R Mato & S M Luger. (2006) Autologous stem cell transplant in ALL: who should we be transplanting in first remission?. Bone Marrow Transplantation 37:11, pages 989-995.
Crossref
F Ravandi. (2006) Role of cytokines in the treatment of acute leukemias: a review. Leukemia 20:4, pages 563-571.
Crossref
N Dhédin, H Dombret, X Thomas, V Lhéritier, J-M Boiron, F Rigal-Huguet, N Vey, M Kuentz, O Reman, F Witz, A Delannoy, T Kovacsovics, K Bradstock, C Charrin, C Boucheix, J Gabert, D Blaise, D Fière & J-P Vernant. (2005) Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trials. Leukemia 20:2, pages 336-344.
Crossref
Anne-Marie Stoppa, Norbert Vey, Reda Bouabdallah, Catherine Faucher, Régis Costello, Diane Coso, Danielle Sainty, Christine Arnoulet, Marina Lafage, Marie-Joelle Mozziconacci, Didier Blaise, Jean-Albert Gastaut & Dominique Maraninchi. (2006) Pronostic et traitement des leucémies aiguës myéloblastiques. EMC - Hématologie 1:1, pages 1-13.
Crossref
Durjoy Majumder, Debasis Bandyopadhyay, Sarmila Chandra, Ashis Mukhopadhayay, Nandini Mukherjee, Subir K. Bandyopadhyay & Subrata Banerjee. (2005) Analysis of HLA class Ia transcripts in human leukaemias. Immunogenetics 57:8, pages 579-589.
Crossref
Farhad Ravandi & Partow Kebriaei. 2005. Cytokines and Cancer. Cytokines and Cancer 313 331 .
N Vey, R Bouabdallah, A Stoppa, C Faucher, M Lafage, C Chabannon, D Sainty, J Gastaut, D Maraninchi & D Blaise. (2003) Autologous stem cell transplantation for acute myelogenous leukemia in first complete remission: a 6-year follow-up study of 101 patients from a single institution. Bone Marrow Transplantation 33:2, pages 177-182.
Crossref
Charles A. Linker. 2003. Thomas' Hematopoietic Cell Transplantation. Thomas' Hematopoietic Cell Transplantation 1238 1249 .
Anthony S. Stein & Stephen J. Forman. 2003. Thomas' Hematopoietic Cell Transplantation. Thomas' Hematopoietic Cell Transplantation 1221 1237 .
L J Burns, D J Weisdorf, T E DeFor, D H Vesole, T L Repka, B R Blazar, S R Burger, A Panoskaltsis-Mortari, C A Keever-Taylor, M-J Zhang & J S Miller. (2003) IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial. Bone Marrow Transplantation 32:2, pages 177-186.
Crossref
I Avivi & A H Goldstone. (2003) Bone marrow transplant in Ph+ ALL patients. Bone Marrow Transplantation 31:8, pages 623-632.
Crossref
Anthony S. SteinMargaret R. O’DonnellMarilyn L. SlovakDavid S. SnyderAuayporn P. NademaneePablo ParkerArturo MolinaGeorge SomloHenry C. FungAmrita KrishnanRoberto RodriguezRicardo T. SpielbergerShirong WangAndrew DagisNayana VoraDaniel A. ArberJoyce C. NilandStephen J. Forman. (2003) Interleukin-2 After Autologous Stem-Cell Transplantation for Adult Patients With Acute Myeloid Leukemia in First Complete Remission. Journal of Clinical Oncology 21:4, pages 615-623.
Crossref
Edward A Stadtmauer. (2002) Histamine dihydrochloride and interleukin-2 in the treatment of acute myeloid leukemia. Seminars in Oncology 29:3, pages 47-51.
Crossref
Thomas G. Martin & Charles A. Linker. (2001) Autologous Stem Cell Transplantation for Acute Lymphocytic Leukemia in Adults. Hematology/Oncology Clinics of North America 15:1, pages 121-143.
Crossref
SL Goldberg, AL Pecora, RJ Rosenbluth, AA Jennis & RA Preti. (2000) Treatment of leukemic relapse following unrelated umbilical cord blood transplantation with interleukin-2: potential for augmenting graft-versus-leukemia and graft-versus-host effects with cytokines. Bone Marrow Transplantation 26:3, pages 353-355.
Crossref
Brad Spellberg & Gary J. Schiller. (1999) AUTOLOGOUS BONE MARROW TRANSPLANTATION IN ACUTE LEUKEMIA. Hematology/Oncology Clinics of North America 13:5, pages 919-938.
Crossref
Deborah A. Thomas, Hagop Kantarjian, Terry L. Smith, Charles Koller, Jorge Cortes, Susan O'Brien, Francis J. Giles, James Gajewski, Sherry Pierce & Michael J. Keating. (1999) Primary refractory and relapsed adult acute lymphoblastic leukemia. Cancer 86:7, pages 1216-1230.
Crossref
Jorge E. Cortes, Hagop M. Kantarjian, Susan O'Brien, Francis Giles, Michael J. Keating, Emil J. Freireich & Elihu H. Estey. (1999) A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remission. Cancer 85:7, pages 1506-1513.
Crossref
Didier Blaise & Dominique Maraninchi. (1998) Interleukin 2 in the treatment of acute leukemia. Leukemia Research 22:12, pages 1165-1170.
Crossref
Thierry GuillaumeDaniel B. RubinsteinMichel Symann. (1998) Immune Reconstitution and Immunotherapy After Autologous Hematopoietic Stem Cell Transplantation. Blood 92:5, pages 1471-1490.
Crossref
Thierry GuillaumeDaniel B. RubinsteinMichel Symann. (1998) Immune Reconstitution and Immunotherapy After Autologous Hematopoietic Stem Cell Transplantation. Blood 92:5, pages 1471-1490.
Crossref
Gérald Marit. (1998) Place des cytokines dans le traitement des leucémies. Annales de l'Institut Pasteur / Actualités 9:2, pages 131-140.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.